|
|
||||||||
The Journal of Immunology, Vol 156, Issue 12 4789-4796, Copyright © 1996 by American Association of Immunologists
ARTICLES |
C Capodici and J Weiss
Department of Microbiology, New York University School of Medicine, New York 10016, USA.
An N-terminal fragment (residues 1-199) of the 456-residue human bactericidal/permeability-increasing protein (BPI), isolated after limited proteolysis, exhibits antibacterial and LPS-neutralizing activities equal to or greater than those of holo-BPI. To assess minimal structural requirements for bioactivity, mutant species of BPI were expressed in vivo by transient transfection and in vitro by cellfree transcription/translation. BPI1-456 and BPI1-193 demonstrated the expected antibacterial and LPS-binding activities. Deletion of the N-terminal 12 residues did not diminish BPI function. However, further truncation either from the C-terminus to residue 169 (BPI1-169) or from the N-terminus (BPIdelta15-56) yielded in vitro products with little or no LPS-binding activity and in vivo products that could not be recovered from the culture medium or cellular acid extracts. The possible role of cysteine-175 (the three cysteines in human BPI are at residues 132, 135, and 175) in BPI stability/function was examined by substitution of Cys(175) with serine. Recovery of C175S BPI from extracellular medium was reduced 10-fold, and C175S BPI produced in vitro had little LPS-binding activity. Compared with wild-type holo-BPI and BPI1-193, BPI1-169, BPIdelta15-56, and C175S BPI showed increased susceptibility to cleavage by elastase in the region 1-193 (but not in the region 200-456), indicating conformational changes that may account for the loss of function. These findings suggest that the proteolytic N- terminal fragment of BPI corresponds closely to the minimum functional (antibacterial/anti-LPS) domain of BPI and that residues near both ends of this fragment are essential for structural stability and functional integrity.
This article has been cited by other articles:
![]() |
M. Gonzalez, Y. Gueguen, D. Destoumieux-Garzon, B. Romestand, J. Fievet, M. Pugniere, F. Roquet, J.-M. Escoubas, F. Vandenbulcke, O. Levy, et al. Evidence of a bactericidal permeability increasing protein in an invertebrate, the Crassostrea gigas Cg-BPI PNAS, November 6, 2007; 104(45): 17759 - 17764. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lennartsson, K. Pieters, K. Vidovic, and U. Gullberg A murine antibacterial ortholog to human bactericidal/permeability-increasing protein (BPI) is expressed in testis, epididymis, and bone marrow J. Leukoc. Biol., March 1, 2005; 77(3): 369 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.E. LeClair Four Reasons to Consider a Novel Class of Innate Immune Molecules in the Oral Epithelium J. Dent. Res., December 1, 2003; 82(12): 944 - 950. [Abstract] [Full Text] |
||||
![]() |
N. Iovine, J. Eastvold, P. Elsbach, J. P. Weiss, and T. L. Gioannini The Carboxyl-terminal Domain of Closely Related Endotoxin-binding Proteins Determines the Target of Protein-Lipopolysaccharide Complexes J. Biol. Chem., March 1, 2002; 277(10): 7970 - 7978. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schultz, J. Weiss, S. F. Carroll, and W. L. Gross The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies J. Leukoc. Biol., April 1, 2001; 69(4): 505 - 512. [Abstract] [Full Text] |
||||
![]() |
E. Bülow, U. Gullberg, and I. Olsson Structural requirements for intracellular processing and sorting of bactericidal/permeability-increasing protein (BPI): comparison with lipopolysaccharide-binding protein J. Leukoc. Biol., November 1, 2000; 68(5): 669 - 678. [Abstract] [Full Text] |
||||
![]() |
J. Huuskonen, G. Wohlfahrt, M. Jauhiainen, C. Ehnholm, O. Teleman, and V. M. Olkkonen Structure and phospholipid transfer activity of human PLTP: analysis by molecular modeling and site-directed mutagenesis J. Lipid Res., June 1, 1999; 40(6): 1123 - 1130. [Abstract] [Full Text] |
||||
![]() |
N. M. Iovine, P. Elsbach, and J. Weiss An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains PNAS, September 30, 1997; 94(20): 10973 - 10978. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Tobias, K. Soldau, N. M. Iovine, P. Elsbach, and J. Weiss Lipopolysaccharide (LPS)-binding Proteins BPI and LBP Form Different Types of Complexes with LPS J. Biol. Chem., July 25, 1997; 272(30): 18682 - 18685. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Beamer, S. F. Carroll, and D. Eisenberg Crystal Structure of Human BPI and Two Bound Phospholipids at 2.4 Angstrom Resolution Science, June 20, 1997; 276(5320): 1861 - 1864. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |